These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38301402)

  • 21. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical revision of the medical treatment of gout in Brazil.
    Azevedo VF; Lopes MP; Catholino NM; Paiva EDS; Araújo VA; Pinheiro GDRC
    Rev Bras Reumatol Engl Ed; 2017; 57(4):346-355. PubMed ID: 28743362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gout. What's up doc?
    Pérez Ruiz F; Pérez Herrero N; Gantes Pedraza MÁ
    Med Clin (Barc); 2022 Jun; 158(12):615-621. PubMed ID: 35177268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on gout and hyperuricemia.
    Baker JF; Schumacher HR
    Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gout].
    Scuiller A; Pascart T; Bernard A; Oehler E
    Rev Med Interne; 2020 Jun; 41(6):396-403. PubMed ID: 32201015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.
    Cottrell E; Crabtree V; Edwards JJ; Roddy E
    BMC Fam Pract; 2013 Nov; 14():170. PubMed ID: 24225170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Febuxostat.
    Hair PI; McCormack PL; Keating GM
    Drugs; 2008; 68(13):1865-74. PubMed ID: 18729537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of hyperuricemia with urate deposition.
    Desideri G; Puig JG; Richette P
    Curr Med Res Opin; 2015; 31 Suppl 2():27-32. PubMed ID: 26414734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gout and its management.
    Dalbeth N; Te Karu L; Stamp LK
    Intern Med J; 2024 May; 54(5):716-723. PubMed ID: 38654576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What do I need to know about gout?
    Becker MA; Ruoff GE
    J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing paradigms in the management of gout.
    Nuki G; Riches P
    J R Coll Physicians Edinb; 2020 Jun; 50(2):124-132. PubMed ID: 32568281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on gout 2012.
    So A; Busso N
    Joint Bone Spine; 2012 Dec; 79(6):539-43. PubMed ID: 23165182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
    Chaichian Y; Chohan S; Becker MA
    Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gout.
    Dalbeth N; Merriman TR; Stamp LK
    Lancet; 2016 Oct; 388(10055):2039-2052. PubMed ID: 27112094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.